O que significa “Limpar”?
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Discover the importance of the DNA test for Congenital Myasthenic Syndrome (CMS) in Jack Russell Terriers, a genetic disorder affecting muscle function. Early detection through this specialized DNA test helps breeders identify carriers and prevent the spread of CMS in future generations. By screening your Jack Russell Terrier, you ensure healthier puppies and reduce the risk of muscle weakness and related symptoms. This reliable genetic test is essential for responsible breeding practices and maintaining the breed’s vitality. Protect your dog’s health with the CMS DNA test and promote a stronger, more active Jack Russell Terrier lineage. Stay informed and prioritize genetic testing today!
Congenital Myasthenic Syndrome (CMS) is a genetic disorder affecting Jack Russell Terriers, causing muscle weakness and fatigue. A DNA test can identify carriers and affected dogs by detecting mutations linked to CMS. Early diagnosis through testing helps breeders make informed decisions to reduce the incidence of the disease. This ensures healthier puppies and improves the overall well-being of the breed. Regular screening is essential for responsible breeding practices.
Este teste de DNA está incluído a partir do nosso pacote Basic - e também faz parte dos packs Basic, Standard, Advanced, Complete.
Ver pacotes de teste de DNA →Congenital Myasthenic Syndrome (CMS) is a genetic disorder that affects the neuromuscular junction, the site where nerve cells communicate with muscles. In Jack Russell Terriers, CMS manifests as muscle weakness due to impaired transmission of nerve impulses to the muscles. This condition is caused by genetic mutations that disrupt the normal functioning of proteins involved in neurotransmission.
Dogs with CMS typically exhibit signs of muscle weakness that can vary in severity. Common symptoms include exercise intolerance, difficulty in climbing stairs, and an overall lethargic demeanor. Additionally, affected dogs may experience episodes of weakness that worsen after physical activity or during times of stress. These symptoms can make it challenging for owners to manage their pet’s daily activities and overall quality of life.
The genetic mutations responsible for CMS in Jack Russell Terriers primarily affect genes associated with the structure and function of the neuromuscular junction. The most common mutations are found in genes encoding proteins such as acetylcholine receptors and other related components critical for muscle contraction. Understanding these genetic factors is essential for diagnosing and managing the condition effectively.
Diagnosing CMS typically involves a combination of clinical evaluation and genetic testing. Veterinary professionals will assess the dog's clinical signs, review its medical history, and perform neurological examinations. Genetic testing can confirm the presence of specific mutations associated with CMS, providing a definitive diagnosis and assisting in the management of the condition.
While there is currently no cure for CMS, various management strategies can help improve the quality of life for affected dogs. Treatment may include medications that enhance neuromuscular transmission, such as acetylcholinesterase inhibitors. Additionally, supportive care, including physical therapy and nutrition management, plays a crucial role in maintaining muscle strength and overall health.
The prognosis for Jack Russell Terriers diagnosed with CMS varies based on the severity of the condition and the specific genetic mutation involved. With appropriate management and care, many dogs can lead relatively normal lives, although they may require ongoing veterinary attention and lifestyle adjustments to accommodate their condition. Regular follow-ups with a veterinarian are essential for monitoring the dog's health and adjusting treatment plans as necessary.
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Não. O animal é geralmente saudável, mas pode transmitir a mutação ao seu descendência.
Ele carrega duas cópias mutadas. Os sinais clínicos são esperados dependendo a doença. Não deveria ser criado.
Algumas doenças estão ligadas ao sexo, pelo que a sua expressão varia dependendo do sexo do animal.
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome In Jack Russell Terrier (CMS-JRT) in order to identify clear, carrier, or at-risk animals.
Os testes de DNA ajudam os criadores a planejar acasalamentos mais seguros e a reduzir o risco de transmissão da mutação aos descendentes.
O modo de herança relatado para este teste é Autossômico Recessivo.
This test analyses the mutation CHRNE c.636_637insC.
Não necessariamente. A interpretação depende do padrão de herança e do genótipo resultante.
Rinz Caitlin J, Lennon Vanda A, James Fiona, Thoreson James B, Tsai Kate L, StarrMoss Alison N, Humphries H Dale, Guo Ling T, Palmer Anthony C, Clark Leigh Anne, Shelton G Diane. A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers. Neuromuscul Disord. 2015 Dec;25(12):921-7. doi: 10.1016/j.nmd.2015.09.005. Epub 2015 Sep 8.
Sua privacidade, sua escolha
Usamos cookies essenciais para operar o site. Cookies opcionais (como provedores de conteúdo incorporados) estão desabilitados por padrão e só são habilitados se você concordar. Você pode alterar sua escolha a qualquer momento através do botão “Cookies”.
Necessário para recursos básicos e segurança. Sempre habilitado.
Melhora recursos como salvamento de preferências ou incorporações não publicitárias.
Ajuda-nos a entender o uso do site. Desativado por padrão.
Publicidade/rastreamento em sites (algumas incorporações de vídeos/mapas). Desativado por padrão.